3654 results for «205»
3654 results
Mastering PCI in patients with complex lesions, ACS and HBR
22 Dec 2021 – From GulfPCR-GIM 2021
Watch this video if you wish to learn how to treat patients with complex anatomy, HBR feature, and presenting with ACS, to discuss the latest evidence about DAPT in HBR patients with acute coronary syndrome, and to ask open questions about DAPT for HBR patients.
Align to a line: improve clinical outcome of current and future patients with the Evolut platform
22 Dec 2021 – From GulfPCR-GIM 2021
Thanks to this session, aimed at revealing the exceptional performance of Evolut PRO+, learn key considerations for patients with longer life expectancy and explore the pathway to a single-digit pacemaker post-TAVI.
Pushing boundaries in tricuspid therapy - The TricValve solution
22 Dec 2021 – From GulfPCR-GIM 2021
In this session, learn about the TricValve system in the treatment of severe TR and right heart disease, obtain insight from the experts with case scenarios, and understand how the TricValve Transcatheter Bicavel system can help patients with severe TR.
Optimising TAVI results in patients with small aortic annuli
22 Dec 2021 – From GulfPCR-GIM 2021
This session will enable you to discuss the clinical outcomes of TAVI results in patients with small aortic annuli, learn how to best measure and assess gradients when performing TAVI, and review a case of a patient with small annuli treated with TAVI.
Complete revascularisation: from defining PCI strategy to PCI optimisation
22 Dec 2021 – From GulfPCR-GIM 2021
In this session on percutaneous coronary intervention, learn about available physiology tools for a full coronary assessment, understand how OCT impacts decision-making to strategise and optimise PCI, and learn through case examples how the use of physiology and OCT impacts daily practice.
Approach to calcified lesions and role of plaque modification and intravascular imaging to obtain optimal PCI - Session with LIVE case
15 Dec 2021 – From GulfPCR-GIM 2021
Watch the case of a 55-year-old male patient who is a diabetic on insulin and hypotensive, who initially presented with NSTEMI and 3-vessel disease but declined CABG before being readmitted with unstable angina.
Year in review: the most impactful trials and papers in interventional cardiology in 2021
16 Dec 2021 – From GulfPCR-GIM 2021
While reflecting on the real academic milestones in the last couple of years, get key learnings for clinical practice from five selected trials published in 2021, and examples of how to critically appraise the internal and external validity of randomised clinical trials, among others.
From TAVI to mitral and tricuspid - Applying evidence to expand patients' treatment options
21 Nov 2021 – From PCR London Valves 2021
Nowadays, there is an increasing range of treatment options as far as tricuspid and mitral regurgitations are concerned. Bernard Prendergast, Philipp Lurz, Fabien Praz and Maurizio Taramasso discuss the challenges and needs regarding mitral and tricuspid valve disease treatment. They also consider what is needed to...
Best cases session
21 Nov 2021 – From PCR London Valves 2021
This session from the PCR London Valves 2021 Congress compiles a series of the best cases submitted during this edition. Discover, among others, cases of severe aortic valve and ostial coronary disease, as well as transcatheter valvular lithotripsy in cases with severely calcific aortic or mitral...
TOP-CABG: the timing of platelet inhibition after coronary artery bypass grafting trial
02 Sep 2025
Jonathan Curio provides his take on TOP-CABG, presented by Xin Yuan at ESC Congress 2025 in Madrid.

Author
Randomised comparison of intravascular lithotripsy vs. cutting balloon treatment in calcified coronary artery disease – The Short-CUT trial
27 Oct 2025
Aaysha Cader provides her take on the Short-CUT trial presented by Suzanne J. Baron at TCT 2025, in San Francisco.

Author
Why hypertension is a major unresolved problem
02 Oct 2024
Explore the global challenge of hypertension, affecting one in three adults, and the strategies for screening, diagnosis, and management, including lifestyle modifications, pharmacotherapy, and device-based treatments, as outlined by Sofie Brouwers.

Author
Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR
29 Mar 2025
Daniele Giacoppo and Nicola Ammirabile provide their take on the main results of the HOST-BR trial, presented by Hyo-Soo Kim at ACC.25 in Chicago.

Author

Author
DAPT-SHOCK-AMI trial: Cangrelor in cardiogenic shock
03 Sep 2025
Kalaivani Mahadevan and Fizzah Choudry provide their take on DAPT-SHOCK-MI presented by Zuzana Motovska at ESC Congress 2025 in Madrid.

Author

Author